Search by Drug Name or NDC

    NDC 70700-0262-30 Lansoprazole 15 mg/1 Details

    Lansoprazole 15 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Xiromed LLC. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 70700-0262
    Product ID 70700-262_ce9167b4-3b92-9cbd-f4f5-a8788ed0d47a
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Xiromed LLC
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203203
    Listing Certified Through 2024-12-31

    Package

    NDC 70700-0262-30 (70700026230)

    NDC Package Code 70700-262-30
    Billing NDC 70700026230
    Package 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70700-262-30)
    Marketing Start Date 2018-08-24
    NDC Exclude Flag N
    Pricing Information N/A